We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EUSA Pharma Handed Untitled Letter for Exclusion of Warning
EUSA Pharma Handed Untitled Letter for Exclusion of Warning
December 16, 2011
The FDA has handed an untitled letter to EUSA Pharma for promotional material that omitted contraindications and warnings about its prostate cancer diagnostic imaging agent.